OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
September 02, 2011
International Federation of Pharmaceutical Manufacturers and Associations takes global action to improve public health.
Industry buy-in is increasing as pharma companies proceed with select projects and research.
Researchers at MIT and Harvard University report on new methods for producing microscale hydrogels.
Biocatalysis, chemocatalysis, and other chiral technologies continue to attract the investment dollars of CMOs and fine-chemical companies.
September 01, 2011
As contract manufacturers and fine-chemical suppliers gather for CPhI/ICSE, effective strategies for technology differentiation are key in an increasingly competitive environment.
August 25, 2011
To further enhance its position in clinical-trial materials supply, Catalent Pharma Solutions has agreed to acquire the clinical-trial supplies business of Aptuit for $410 million on a cash and debt-fee basis.